Associations of Vitamin D Level and Glucoregulatory Parameters in Type 2 Diabetes Mellitus

1. KAl-Shoumer ASK, Al-Essa MT. Is there a relationship between vitamin D with insulin resistance and diabetes mellitus. World J Diabetes. 2015; 6(8): 1057-64.10.4239/wjd.v6.i8.1057451544526240702 Search in Google Scholar

2. Gedik O, Akahn S. Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia. 1986; 29(3): 142–5.10.1007/BF024270833516771 Search in Google Scholar

3. Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008; 10(3): 185-97.10.1111/j.1463-1326.2007.00710.x18269634 Search in Google Scholar

4. Naumovic N. Vitamin D-physiological importance. Med Pregl. 2010; 63 (5-6):301-4. Search in Google Scholar

5. Witham MD, Dove FJ, Dryburgh M, Sugden JA, Morris AD, Struthers AD. The effect of different doses of vitamin D on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia. 2010; 53(10): 2112-9.10.1007/s00125-010-1838-120596692 Search in Google Scholar

6. Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr. 2009; 48(6): 349-54.10.1007/s00394-009-0020-319370371 Search in Google Scholar

7. Talaei A, Mohamadi M, Adgi Z. The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetol Metab Syndr. 2013; 5(1): 8.10.1186/1758-5996-5-8358656923443033 Search in Google Scholar

8. Kumar S, Davies M, Zakaria Y, Mawer EB, Gordon C, Olukoga AO, Boulton AJ. Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D. Postgrad Med J. 1994; 70(824): 440-3.10.1136/pgmj.70.824.44023977318029165 Search in Google Scholar

9. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007; 30(4): 980-6.10.2337/dc06-199417277040 Search in Google Scholar

10. American Diabetes Association. Classification and diagnosis of diabetes. Sec. 2. In Standards of Medical Care in Diabetes—2015. Diabetes Care 2015; 38(Suppl. 1): S8–S1610.2337/dc15-S00525537714 Search in Google Scholar

11. Munns CF, Shaw N, Kiely M, et al. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. J Clin Endocrinol Metab. 2016; 101(2): 394–415.10.1210/jc.2015-2175488011726745253 Search in Google Scholar

12. Wallace T, Levy J, Matthews D. Use and abuse of HOMA modeling. Diabetes Care. 2004; 27(6): 1487-95.10.2337/diacare.27.6.148715161807 Search in Google Scholar

13. Mattila C, Knekt P, Mannist OS, Rissanen H, Maarit A. Laaksonen M, et al. Serum 25-Hydroxyvitamin D Concentration and Subsequent Risk of Type 2 Diabetes. Diabetes care.2007; 30(10): 2569-70.10.2337/dc07-029217626891 Search in Google Scholar

14. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE, et all. Vitamin D and calcium in-take in relation to type 2 diabetes in women. Diabetes Care. 2006; 29(3): 650-6.10.2337/diacare.29.03.06.dc05-196116505521 Search in Google Scholar

15. Mcgill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J. 2008; 28; 7:4.10.1186/1475-2891-7-4226573818226257 Search in Google Scholar

16. Drincic A, Armas L, Van Diest E, Heaney R. Volumetric Dilution, Rather Than Sequestration Best Explains the Low Vitamin D Status of Obesity. Obesity (Silver Spring). 2012; 20(7): 1444-8.10.1038/oby.2011.40422262154 Search in Google Scholar

17. Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, et all. HOMA-Estimated Insulin Resistance Is an Independent Predictor of Cardiovascular Disease in Type 2 Diabetic Subjects. Diabetes Care. 2002; 25(7): 1135-41.10.2337/diacare.25.7.113512087010 Search in Google Scholar

18. Yoon H, Jeon DJ, Park CE, You HS, Moon AE. Relationship between homeostasis model assessment of insulin resistance and beta cell function and serum 25-hydroxyvitamin D in non-diabetic Korean adults. J Clin Biochem Nutr. 2016; 59(2): 139-144.10.3164/jcbn.15-143501856727698542 Search in Google Scholar

19. Schuit FC. Factors determining the glucose sensitivity and glucose responsiveness of pancreatic beta cells. Horm Res. 1996; 46(3): 99-106.10.1159/0001850048894663 Search in Google Scholar

20. Tengholm A. Cyclic AMP dynamics in the pancreatic b-cell. Ups J Med Sci. 2012; 117(4): 355-69.10.3109/03009734.2012.724732349722022970724 Search in Google Scholar

21. Seino Y, Kurahachi H, Goto Y, Taminato T, Ikeda M, Imura H. Comparative insulinogenic effects of glucose, arginine and glucagon in patients with diabetes mellitus, endocrine disorders and liver disease. Acta Diabetol Lat. 1975; 12(2): 89-99.10.1007/BF02624728769464 Search in Google Scholar

22. Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. PNAS. 1987; 84(10): 3434–8.10.1073/pnas.84.10.3434 Search in Google Scholar

23. Bourlon P-M, B Billaudel B, Faure-Dussert A. Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol. 1999; 160(1): 87-95.10.1677/joe.0.1600087 Search in Google Scholar

24. Berg JP, Haug E. Vitamin D: a hormonal regulator of the cAMP signaling pathway. Crit Rev Biochem Mol Biol. 1999; 34(5): 315-23.10.1080/10409239991209327 Search in Google Scholar

25. Rudack-Garcia D, Henry H. Effect of Vitamin D Status on Cyclic AMP-dependent Protein Kinase Activity and Its Heat-stable Inhibitor in Chick Kidney. J biol chem. 1981; 256(21): 10781-5.10.1016/S0021-9258(19)68510-8 Search in Google Scholar

26. Vazquez G, Boland R, de Boland A. Modulation by 1,25(OH)₂-vitamin D₃ of the adenylyl cyclase/cyclic AMP pathway in rat and chick myoblasts. BBA-mol cell res. 1995; 1269(1): 91–7.10.1016/0167-4889(95)00097-C Search in Google Scholar

27. Nilas L, Christiansen C. Treatment with vitamin D or its analogues does not change body weight or blood glucose level in postmenopausal women. Int J Obes. 1984; 8(5): 407-11. Search in Google Scholar

28. Boucher BJ, Mannan N, Noonan K, et al. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia. 1995; 38(10): 1239-45.10.1007/BF004223758690178 Search in Google Scholar

29. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr. 2010; 103(4): 549-55.10.1017/S000711450999201719781131 Search in Google Scholar

30. Jeddi S, Syedmoradi L, Bagheripour F, Ghasemi A. The Effects of Vitamin D on Insulin Release From Isolated Islets of Rats. IntJEndocrinolMetab. 2015; 13(1): e20620.10.5812/ijem.20620433866825745495 Search in Google Scholar

31. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J ClinNutr. 2004; 79(5): 820-5.10.1093/ajcn/79.5.820 Search in Google Scholar

32. Hedblad B, Nilsson P, Janzon L, Berglund G: Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmo, Sweden. Diabet Med 2000;17:299-30710.1046/j.1464-5491.2000.00280.x10821297 Search in Google Scholar